Steris (STE) Tops Q1 EPS by 14c ; Offers Guidance
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $232.64 --0%
EPS Growth %: +8.5%
Financial Fact:
Total operating expenses: 186.66M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: +8.5%
Financial Fact:
Total operating expenses: 186.66M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q1 EPS of $2.74, $0.14 better than the analyst estimate of $2.60. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.
GUIDANCE:
Steris sees FY2025 EPS of $9.90-$10.15, versus the consensus of $9.06.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
